Safety of Prescription Nonsteroidal Anti-inflammatory Drugs in Adults With Inflammatory Bowel Disease: Data From a Large Administrative Claims Cohort - Summary - MDSpire
To systematically evaluate the association of severe IBD flares with prescription NSAID exposure across IBD subtypes and NSAID formulations.
Approach:
Matching Methodology: Exposed patients were matched to unexposed patients based on age, calendar year, and other relevant clinical characteristics to minimize confounding.
Key Findings:
NSAID exposure was not associated with a meaningful increase in IBD-related hospitalization in patients with ulcerative colitis.
Similar conclusions could not be definitively reached for patients with Crohn disease.
Over half of NSAID-exposed individuals had a recent code for joint or chronic musculoskeletal pain.
Interpretation:
Limitations:
Previous studies attributing risk to NSAID exposure may have suffered from residual confounding and reverse causality.
Small sample sizes in earlier studies limited statistical power and subgroup analyses.
Conclusion:
The study provides insights into the safety of NSAIDs in IBD patients, but the risk associated with NSAID exposure in IBD remains inconclusive.
